RAD001 in Recurrent Endometrial Cancer Patients
NCT00087685
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
RAD001
Sponsor
M.D. Anderson Cancer Center